Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kent

Showing results (1001-1010 of 1,075) with videos related to

Pageof 108
Sort By:
The American Journal of Cardiology|July 21, 2010
Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarctionKohei Wakabayashi, Manuel A Gonzalez, Cedric Delhaye, et al.
The American Journal of Cardiology|February 24, 2009
Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native arteryAxel De Labriolle, Gilles Lemesle, Laurent Bonello, et al.
Circulation. Cardiovascular Interventions|February 10, 2012
Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosisGabriel Maluenda, Itsik Ben-Dor, Michael A Gaglia, et al.
The American Journal of Cardiology|May 25, 2010
Prognosis of asymptomatic coronary artery disease after percutaneous coronary interventionKohei Wakabayashi, Cedric Delhaye, Gabriel Maluenda, et al.
Kidney International|April 12, 2000
Comparative mortality of hemodialysis and peritoneal dialysis in CanadaS W Murphy, R N Foley, B J Barrett, et al.
The American Journal of Cardiology|February 2, 2008
Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary interventionProbal Roy, Ashesh N Buch, Aamir Javaid, et al.
JACC. Advances|June 28, 2024
Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 DiabetesRozalina G McCoy, Kavya Sindhu Swarna, Yihong Deng, et al.
The American Journal of Cardiology|March 10, 2010
Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomesMichael A Gaglia, Rebecca Torguson, Nicholas Hanna, et al.
American Journal of Obstetrics and Gynecology|July 28, 2012
Placental pathology, birthweight discordance, and growth restriction in twin pregnancy: results of the ESPRiT StudyEtaoin M Kent, Fionnuala M Breathnach, John E Gillan, et al.
The American Journal of Cardiology|August 10, 2010
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry)Nicholas N Hanna, Michael A Gaglia, Rebecca Torguson, et al.
Pageof 108

Showing results (1001-1010 of 1,075) with videos related to

Sort By:
Pageof 108
The American Journal of Cardiology|July 21, 2010
Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarctionKohei Wakabayashi, Manuel A Gonzalez, Cedric Delhaye, et al.
The American Journal of Cardiology|February 24, 2009
Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native arteryAxel De Labriolle, Gilles Lemesle, Laurent Bonello, et al.
Circulation. Cardiovascular Interventions|February 10, 2012
Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosisGabriel Maluenda, Itsik Ben-Dor, Michael A Gaglia, et al.
The American Journal of Cardiology|May 25, 2010
Prognosis of asymptomatic coronary artery disease after percutaneous coronary interventionKohei Wakabayashi, Cedric Delhaye, Gabriel Maluenda, et al.
Kidney International|April 12, 2000
Comparative mortality of hemodialysis and peritoneal dialysis in CanadaS W Murphy, R N Foley, B J Barrett, et al.
The American Journal of Cardiology|February 2, 2008
Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary interventionProbal Roy, Ashesh N Buch, Aamir Javaid, et al.
JACC. Advances|June 28, 2024
Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 DiabetesRozalina G McCoy, Kavya Sindhu Swarna, Yihong Deng, et al.
The American Journal of Cardiology|March 10, 2010
Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomesMichael A Gaglia, Rebecca Torguson, Nicholas Hanna, et al.
American Journal of Obstetrics and Gynecology|July 28, 2012
Placental pathology, birthweight discordance, and growth restriction in twin pregnancy: results of the ESPRiT StudyEtaoin M Kent, Fionnuala M Breathnach, John E Gillan, et al.
The American Journal of Cardiology|August 10, 2010
Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry)Nicholas N Hanna, Michael A Gaglia, Rebecca Torguson, et al.
Pageof 108